Mike Kelly is not making headlines today. Google News shows zero stories in the last 24 hours. But his brokerage account had a busy July 17, and the public disclosure record is sitting right there for anyone who wants to look.
The Pennsylvania Republican, a Ways and Means member representing the 16th district, filed three stock sales on the same date: Abbott Laboratories ($1,001–$15,000), PepsiCo ($15,001–$50,000), and Walt Disney ($1,001–$15,000). All three cleared on July 17, 2026. His full disclosure record is on Blind Trust.
The Scorecard
Blind Trust scores trades against the S&P 500 on a 30-day alpha basis. Kelly's July 17 triple-sale produced a mean 30-day alpha of negative 4.1 percent across four scored trades. One positive, three negative. Full sample, not a cherry-picked slice.
- Abbott Laboratories (ABT), Sale, July 17: +3.0% alpha over 30 days. The one winner — and the smallest position by disclosed range.
- Walt Disney (DIS), Sale, July 17: −2.3% alpha. The stock went up after he sold it.
- PepsiCo (PEP), Sale, July 17: −2.6% alpha. Also went up after he sold it. His largest disclosed position, up to $50,000.
Selling a stock that then rises is the outcome a trader does not want. Kelly did it twice in a single session. Blind Trust's scoring methodology compares each trade's 30-day return against the S&P 500 benchmark — these are underperformances relative to holding an index fund and doing nothing. One positive out of four scored trades. Seventy-five percent of his recent disclosed sales moved against him within 30 days of execution.
What Kelly Actually Oversees
Kelly sits on the House Committee on Ways and Means, including its Health and Tax subcommittees — the committee that writes tax law and shapes Medicare and Medicaid reimbursement rates. Abbott Laboratories manufactures medical devices and diagnostics, squarely in territory Ways and Means touches. PepsiCo operates in a consumer staples sector the committee reaches through excise taxes and nutrition policy.
Blind Trust's data shows zero committee overlap trades in Kelly's scored sample — none of the three sales have been formally flagged as falling within the remit of his committee assignments. A Ways and Means member selling Abbott raises an eyebrow, but the scoring system hasn't tagged it as an overlap, and we're not calling it one unilaterally. The record is public. Readers who want to draw lines can draw them.
Kelly also voted on September 15, 2026, for H.R. 8278, the Fostering the Use of Technology to Uphold Regulatory Effectiveness in Supervision Act, a bill aimed at modernizing regulatory examination tools for financial institutions. It passed. His Ways and Means seat doesn't put bank regulation in his direct oversight lane, so this is a floor vote, not a committee moment — but it's in the record.
The July 22 Votes
Five days after selling those three positions, Kelly was on the House floor voting on the National Defense Authorization Act for Fiscal Year 2027 (H.R. 8800). He voted yes on the final bill, which passed. He also voted yes on an amendment codifying chaplain protections under the Uniform Code of Military Justice, yes on prohibiting automated speed cameras on military installations, and yes on requiring a Pentagon report on cutting 200,000 civilian employees — that last one failed.
He voted no on a Lauren Boebert amendment that would have struck a provision removing the cap on cadets pursuing professional athletic careers instead of military service. That amendment also failed.
None of Kelly's three July 17 sales map to defense contractors or military-adjacent holdings. The NDAA votes and the stock sales are five days apart, in separate sectors, with no documented connection. The record notes both happened.
The Quiet Part
Kelly's social presence is minimal. Eleven Bluesky posts in the tracking window, and two of the top three involve different people named Mike Kelly entirely. The third references him saying the FBI hasn't responded to a request made two years ago.
A House Ways and Means member — with a hand in tax and health policy — sold three stocks in a single day in July. Two rose in the 30 days that followed. His aggregate 30-day alpha across all four scored trades sits at negative 4.1 percent. He's not in the news. He's in the disclosure database, which doesn't care whether anyone's paying attention.
Members are required to disclose. They are not required to divest, recuse, or generate headlines. Kelly has checked exactly one of those boxes this week.
The receipts are public. Make of them what you make of them.